Market-Moving News for April 25th
Market-Moving News for April 25th
ULBI: 26% | Ultralife shares are trading higher after the company reported better-than-expected Q1 financial results.
CDTX: 41% | Cidara Therapeutics shares are trading higher after the company announced the divestiture of rezafungin to Mundipharma, reacquired global development and commercial rights to CD388 and announced $240 million in private placement financing.
OPTN: 36% | Optinose Provides Corporate Updates; Expects To Produce Positive Income From Operations For Full Year 2025
ULBI: 26% | Ultralife shares are trading higher after the company reported better-than-expected Q1 financial results.
ULBI：26％ | Ultralife公佈的第一季度財務業績好於預期後，該公司股價走高。
CDTX: 41% | Cidara Therapeutics shares are trading higher after the company announced the divestiture of rezafungin to Mundipharma, reacquired global development and commercial rights to CD388 and announced $240 million in private placement financing.
CDTX：41％ | Cidara Therapeutics宣佈將rezafungin剝離給Mundipharma，重新收購了 CD388 的全球開發和商業權，並宣佈了2.4億美元的私募融資，此後，該公司股價走高。
OPTN: 36% | Optinose Provides Corporate Updates; Expects To Produce Positive Income From Operations For Full Year 2025
OPTN：36% | Optinose提供公司最新情況；預計2025年全年運營收入將爲正數
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧